https://www.avient.com/sites/default/files/resources/19.2540_C%2520Colorant%2520Chromatics%25209001-2015%2520Certificate%2520EXP%25202021%25209-24-2018.pdf
Certificate of Registration 9001:2015 MSP 9001:2015–MSP-ANAB-US (2.0) Page 1 of 2 Certificate of Registration of Quality Management System to ISO 9001:2015 The National Standards Authority of Ireland certifies that: Colorant Chromatics Ab Kroklundsvagen 346 AX-22 320 Odkarby Aland Finland has been assessed and deemed to comply with the requirements of the above standard in respect of the scope of operations given below: The Design, Manufacture and Sales of Fluoropolymer Color Concentrates and Compounds Additional sites covered under this multi-site certification are listed on the Annex (File No. 19.2540/C) Approved by: Geraldine LarkinChief Executive Officer Approved by: Lisa Greenleaf Operations Manager Registration Number: 19.2540/C Certification Granted: May 15, 1997 Effective Date: Oct 20, 2018 Expiry Date: Oct 19, 2021 National Standards Authority of Ireland, 20 Trafalgar Square, Nashua, New Hampshire, NH 03063, USA T +1 603 882 4412 9001:2015–MSP-ANAB-US (2.0) Page 2 of 2 Annex to Certificate Number: 19.2540/C Scope of Registration: The Design, Manufacture and Sales of Fluoropolymer Color Concentrates and Compounds Activity Location Central Management Group, Design, Manufacture Colorant Chromatics Kroklundsvagen 346 AX-22 320 Odkarby Aland Finland File No.: 19.2540/C Headquarters, Sales, Distribution Colorant Chromatics Europe B.V.
https://www.avient.com/sites/default/files/2023-10/31307-Certificate-20SEP2023.pdf
All rights reserved.
All rights reserved. 31307Certificate No: Facility: Avient Corporation - Elk Grove, IL 2400 East Devon Avenue Elk Grove, IL 60007 U.S.A.
All rights reserved. 31307Certificate No: Facility: Avient Corporation - Massillon, OH 1675 Navarre Road Massillon, OH 44646 U.S.A.
https://www.avient.com/sites/default/files/2023-03/2023 Avient Bookmarked Proxy Statement - FINAL.pdf
All Other Fees.
We established threshold, target and maximum adjusted EPS goals for each of the above listed performance periods.
r) “Market Value per Share” means as of any particular date the closing sale price of the Common Shares as reported on the New York Stock Exchange or, if not listed on such exchange, on any other national securities exchange on which the Common Shares are listed.
https://www.avient.com/sites/default/files/2024-09/Compensation Committee Charter July 2024.pdf
AVIENT CORPORATION COMPENSATION COMMITTEE CHARTER Membership • The Committee will consist entirely of directors who meet the definition of “independent” as set forth in the Corporate Governance Standards of the New York Stock Exchange, including the additional independence requirements set forth in New York Stock Exchange Listed Company Manual Section 303A.02(a)(ii). • Members of the Committee will be appointed by the Board each year. • Each Committee member will serve at the pleasure of the Board for such term as the Board may decide or until such Committee member is no longer a Board member. • The Committee shall consist of a minimum of three directors.
Independence Assessment of Outside Advisers • The Committee may select a compensation consultant, legal counsel or other adviser to the Committee or receive advice from a compensation consultant, legal counsel or other adviser (other than in-house legal counsel or any compensation consultant, legal counsel or other adviser whose role is limited to the following activities for which no disclosure would be required under Item 407(e)(3)(iii) of Regulation S-K: consulting on any broad-based plan that does not discriminate in scope, terms, or operation, in favor of executive officers or directors of the Company, and that is available generally to all salaried employees; or providing information that either is not customized for a particular company or that is customized based on parameters that are not developed by the compensation consultant, and about which the compensation consultant does not provide advice) only after taking into consideration all factors relevant to that person’s independence from management, including the following: 5 • the provision of other services to the Company by the employer of the compensation consultant, legal counsel or other adviser; • the amount of fees received from the Company by the employer of the compensation consultant, legal counsel or other adviser, as a percentage of the total revenue of the employer of the compensation consultant, legal counsel or other adviser; • the policies and procedures of the employer of the compensation consultant, legal counsel or other adviser that are designed to prevent conflicts of interest; • any business or personal relationship of the compensation consultant, legal counsel or other adviser with a member of the Committee; • any stock of the Company owned by the compensation consultant, legal counsel or other adviser; and • any business or personal relationship of the compensation consultant, legal counsel, other adviser or the employer of the adviser with an executive officer of the Company. • The Committee shall evaluate whether any compensation consultant retained or to be retained by it has any conflict of interest in accordance with Item 407(e)(3)(iv) of Regulation S-K.
However, the Committee shall meet regularly without such members present, and in all cases the Chief Executive Officer and any other such officers shall not be present at meetings at which their individual compensation or performance is discussed or determined. • The Committee may appoint subcommittees from time to time as needed, each of which will have the specific duties and responsibilities delegated to it by the Committee. • The Committee may delegate its authority under this Charter relating to employees other than executive officers and non-employee directors, to the extent it deems appropriate and consistent with law and customary practice, and may otherwise fully delegate authority relating to matters it deems to be ministerial. • The Committee may delegate its authority under this Charter relating to employee benefit plans in which executive officers participate if such employee benefit plans are broad-based, to the extent it deems appropriate and consistent with law and customary practice. • The Corporate Secretary or designee will be responsible for keeping minutes of the Committee meetings. • The Committee will meet at least four times a year and at such other times as may be requested by the Committee Chair. 6 • The Committee will annually review its charter and recommend any changes to the Governance and Corporate Responsibility Committee.
https://www.avient.com/sites/default/files/2022-07/EHS Committee Charter %28Amended July 2022%29.pdf
• The Committee may appoint subcommittees from time to time as needed, and may delegate authority to such subcommittees or to officers of the Company when appropriate, consistent with applicable laws, regulations and listing standards. • The Corporate Secretary or his/her designee shall be responsible for keeping minutes of the Committee meetings. • The Committee will meet at least two times a year and at such other times as may be requested by its Chair. 3 • The Committee will annually review its charter and recommend any changes to the Governance and Corporate Responsibility Committee.
https://www.avient.com/sites/default/files/2024-03/ISO 9001 - NL027324 Current.pdf
Other sites are listed on the appendix.
https://www.avient.com/sites/default/files/2023-04/Avient_supplierFAQ.pdf
For more information regarding all the CSP benefits and where to find tutorials see CSP section.
Will I need to go through this all over again for those organizations?
I stop my commercial relationship with Avient, how can I request to be removed from Coupa supplier list?
https://www.avient.com/sites/default/files/resources/Polyone%2520AR.pdf
Consequently, you should not consider any such list to be a complete set of all potential risks or uncertainties.
The following discussion is not an all-inclusive listing of risks, although we believe these are the more material risks that we face.
Pune, India 6.
https://www.avient.com/sites/default/files/2023-01/Mevopur Colorants _ Additives Brochure.pdf
The result: an ever-expanding portfolio of colorants and additives that are compatible with all thermoplastic processes utilized by the industry, and that combine creativity with production efficiency for our customers.
The table below shows a non-exhaustive list of additives used in healthcare applications.
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including the suitability of all raw materials and components used for its manufacture.
https://www.avient.com/sites/default/files/2022-06/2021_CDP Supplier Engagement Rating_Avient.pdf
SER_Report_2021 ACTIVITY GROUP PERFORMANCE Trading, wholesale, distribution, rental & leasing Your company is amongst 19% of companies that reached Leadership level in your Activity Group A sample of A-list companies from your Activity Group: Grupo Logista Hilton Food Group plc Lerøy Seafood Group Samsung C&T Avient received a A- which is in the Leadership band.